(2R,3R,4S,5S)-2-(6-Amino-9H-purin-9-yl)-5-((methylthio)methyl)tetrahydrofuran-3,4-diol

Catalog No. :
ACNRKA298
CAS No. :
2457-80-9
Molecular Formula :
C11H15N5O3S
Molecular Weight :
297.34

IUPAC Name:(2R,3R,4S,5S)-2-(6-amino-9H-purin-9-yl)-5-((methylthio)methyl)tetrahydrofuran-3,4-diol

(2R,3R,4S,5S)-2-(6-Amino-9H-purin-9-yl)-5-((methylthio)methyl)tetrahydrofuran-3,4-diol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$58.00Login to see priceIn stockInquiry
1g97%$161.00Login to see priceIn stockInquiry
5g97%$649.00Login to see priceIn stockInquiry
25g97%$2998.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3R,4S,5S)-2-(6-Amino-9H-purin-9-yl)-5-((methylthio)methyl)tetrahydrofuran-3,4-diol
IUPAC Name(2R,3R,4S,5S)-2-(6-amino-9H-purin-9-yl)-5-((methylthio)methyl)tetrahydrofuran-3,4-diol
MDL No.0
Molecular FormulaC11H15N5O3S
Molecular Weight297.34
SMILESCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N
InChI KeyWUUGFSXJNOTRMR-IOSLPCCCSA-N
SynonymVitamin L2 | MFCD00010533 | 5'-(Methylthio)adenosine | 9-(5-S-methyl-5-thio-beta-D-ribofuranosyl)-9H-purin-6-amine | (2R,3R,4S,5S)-2-(6-aminopurin-9-yl)-5-(methylsulfanylmethyl)oxolane-3,4-diol | 5'-DEOXY-5'-METHYLTHIOADENOSINE | 5'-Deoxy-5'-methylthio-ad
CAS No.2457-80-9
PubChem CID439176

Synthetic Route by SureRoute

1. ACNRKA298 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNRKA298 route product structure diagram
    ACNRKA2982457-80-9 In Stock
Inquiry

2. ACNRKA298 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNRKA298 route product structure diagram
    ACNRKA2982457-80-9 In Stock
Inquiry

Comments (0)